Stéphane Depil

发表

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Emmanuel Barillot, Anne Vincent-Salomon, Guillem Rigaill, 2013, PloS one.

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.

Emmanuel Barillot, Anne Vincent-Salomon, Guillem Rigaill, 2013, Cancer research.

Determination of a HLA II Promiscuous Peptide Cocktail as Potential Vaccine Against EBV Latency II Malignancies

Claude Auriault, S. Depil, B. Maillère, 2007, Journal of immunotherapy.

Decoding and unlocking the BCL-2 dependency of cancer cells

Philippe Juin, Mario Campone, M. Campone, 2013, Nature Reviews Cancer.

Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept.

T. Wurch, S. Depil, Thierry Wurch, 2012, Trends in biotechnology.